Savill Corrine
Insider CIK 1837524 · CGEM Chief Business Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CGEM Cullinan Therapeutics, Inc | A Award deriv | 2026-02-18 | 2026-02-19 | 175,000 | — | $0 | 175,000 | SEC↗ |
| CGEM Cullinan Therapeutics, Inc | A Award deriv | 2025-02-19 | 2025-02-21 | 75,000 | — | $0 | 75,000 | SEC↗ |
| CGEM Cullinan Therapeutics, Inc | A Award | 2025-02-19 | 2025-02-21 | 37,500 | — | $0 | 240,990 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | A Award deriv | 2024-02-22 | 2024-02-23 | 75,000 | — | $0 | 75,000 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | A Award | 2024-02-22 | 2024-02-23 | 37,500 | — | $0 | 203,490 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | M Exercise deriv | 2024-02-01 | 2024-02-02 | 40,000 | — | $0 | 70,331 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | M Exercise | 2024-02-01 | 2024-02-02 | 40,000 | $4.30 | $172.0K | 205,990 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | S Sale | 2024-02-01 | 2024-02-02 | 40,000 | $16.18 | $647.2K | 165,990 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | M Exercise deriv | 2024-01-29 | 2024-01-30 | 13,997 | — | $0 | 0 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | M Exercise deriv | 2024-01-29 | 2024-01-30 | 26,003 | — | $0 | 110,331 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | S Sale | 2024-01-29 | 2024-01-30 | 40,000 | $14.09 | $563.6K | 165,990 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | M Exercise | 2024-01-29 | 2024-01-30 | 40,000 | $4.30 | $172.0K | 205,990 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | M Exercise deriv | 2024-01-23 | 2024-01-24 | 21,316 | — | $0 | 13,997 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | S Sale | 2024-01-23 | 2024-01-24 | 21,316 | $12.46 | $265.6K | 165,990 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | M Exercise | 2024-01-23 | 2024-01-24 | 21,316 | $4.30 | $91.7K | 187,306 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | M Exercise deriv | 2024-01-22 | 2024-01-24 | 14,559 | — | $0 | 35,313 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | S Sale | 2024-01-22 | 2024-01-24 | 4,125 | $12.02 | $49.6K | 165,990 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | S Sale | 2024-01-22 | 2024-01-24 | 14,559 | $12.18 | $177.3K | 170,115 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | M Exercise | 2024-01-22 | 2024-01-24 | 14,559 | $4.30 | $62.6K | 184,674 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | A Award deriv | 2023-02-17 | 2023-02-21 | 41,000 | — | $0 | 41,000 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | A Award | 2023-02-17 | 2023-02-21 | 20,500 | — | $0 | 170,115 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | S Sale | 2022-07-19 | 2022-07-21 | 14,958 | $15.22 | $227.7K | 149,615 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | S Sale | 2022-07-18 | 2022-07-21 | 5,042 | $15.06 | $75.9K | 164,573 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | S Sale | 2022-07-11 | 2022-07-12 | 39,800 | $13.33 | $530.5K | 169,815 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | S Sale | 2022-07-11 | 2022-07-12 | 200 | $13.85 | $2.8K | 169,615 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | A Award deriv | 2022-02-11 | 2022-02-15 | 33,000 | — | $0 | 33,000 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | A Award | 2022-02-11 | 2022-02-15 | 16,500 | — | $0 | 209,615 | SEC↗ |